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1. Publications: 
K. Green, C. M. Symonds, R. D. Elijah, L. H. Zalkow, H. M. Deutsch, K. A. Bowman and 
T. R. Morgan, "Water Soluble Marijuana-Derived Material: Pharmacological Action in 
Rabbit and Primate", Current Eye Research, 1, 599 (1982). 
K. Green, "Marijuana and the Eye - A Review", J. Toxicol. Cut. & Ocular Toxicol., 1, 
3 (1982). 
Presentations: 
H. M. Deutsch, L. C. Hodges, L. H. Zalkow and K. Green, "Isolation and Characterization 
of Ocular Hypotensive Agents from Cannabis Saliva: 66th Annual Meeting of the Federation 
of American Societies for Experimental Biology, New Orleans, Louisiana, April 15-23,1982. 
K. Green, H. M. Deutsch, L. C. Hodges, C. M. Symonds, R. D. Elijah and L. H. Zalkow, 
"Characterization of Water-Soluble Ocular Hypotensive Agents from Cannabis Sativa," 
54th Annual ARVO Spring Meeting, Sarasota, Fla., May 3-7, 1982. 
H. M. Deutsch, L. C. Hodges, L. H. Zalkow, and K. Green, "Isolation and Characterization 
of Ocular Hypotensive Agents from Cannabis Sativa," Southeast Regional Meeting of the 
American Chemical Society, Birmingham, Alabama, November 3-5, 1982. 
3. Progress Report  
1. Objectives: 
a. Total Project. 
(1) Isolate and characterize water soluble compound(s) from Cannabis sativa  
which on the basis of screening results have been shown to lower intraocular pressure in 
test animals. 
(2) Based on the results above, synthesize and/or modify the basic structural 
type to develop structural activity data and more effective compounds. 
(3) Synthesize and screen water soluble derivatives of naturally occurring 
cannabinoids. 
(4) Select and screen other plants as possible sources of compounds with 
IOP lowering activity. 
b. Current Year. 
(1) Continue established separation methods, with special emphasis on ion 
exchange and affinity chromatography, gel electrophoresis and isoelectric focusing, until 
a pure active material has been isolated. 
(2) Most of our effort will be geared towards the physical and chemical 
characterization of the above active fraction. Special emphasis will be placed on 
characterization of the carbohydrate portion. 
(3) Selected chemical and biological transformations of the active material 
will be attempted in order to understand which portions of the molecule are necessary for 
IOP lowering activity, and to study its mechanism of action. 
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(4) Screening of other plants will not be emphasized. 
(5) At least one water soluble derivative of a natural cannabinoid will be 
made and screened for activity. 
2. Studies During Current Year: 
A. Isolation and Purification  
The active component(s) from aqueous extracts of Cannabis sativa have been 
successfully fractionated into several high molecular weight species by gel filtration 
chromatography on Fractogel TSK HW 75F. The chromatography was performed in 0.05M 
sodium phosphate, 0.2M LiBr, pH 6.5, conditions which should disrupt aggregation. 
This size exclusion media has a molecular weight range of 1 x 10 5 to 10 x 106 for 
polysaccharides. Samples of extracts partially purified by ion exchange chromatography 
on DEAE cellulose when applied to this material fractionate into three peaks as 
determined by the phenolsulfuric acid test for carbohydrates. The lowest molecular weight 
material elutes last from the column, is highly colored and has no intraocular pressure 
(IOP) lowering activity. The first two fractions from this column contain the active 
material with IOP lowering activity between -30 and -50% at 1 pg/animal. A sample of 
a dextran with known molecular weights was used to calibrate the column. The active 
fractions had molecular weights between 1.5 x 106 and 5 x 105 by this technique. Other 
DEAE-cellulose fractions when passed through this column show similar elution patterns 
but somewhat different composition of the fractions. 	These differences may be due 
to incomplete separation of the three fractions. The high molecular weight of these 
samples makes tests for homogeneity difficult. Conventional methods such as 
polyacrylamide electrophoresis are not useful since such high molecular weight material 
cannot enter the gel matrix. Currently we are exploring the use of agarose as an 
electrophoretic medium since it has essentially no molecular weight occlusion limit. 
In addition to gel filtration techniques for separation, a new ion exchange material, 
DEAE Trisacryl M which is noncellulose-based has been tried. Earlier separations of 
crude, dialyzed extracts had been complicated by nonspecific adsorption phenomena. The 
Trisacryl M support matrix eliminates nonspecific interactions and has a high adsorption 
capacity. An active, crude dialyzed extract applied to this column at low ionic 
strength (0.05M Tris•HC1, pH 8.6) separated into three fractions as monitored by UV 
absorption at 228 nm. Elution with buffer containing 0.25M NaCl gave a large UV 
absorbing fraction which contained the only IOP lowering activity. Further work with 
this ion exchange material will include quantifying recovery on a larger sample, 
rechromatography of active components to enhance separation, and gradient elution. 
Problems have been encountered with extraction of the active material from the 
marijuana samples. The material may not be present in all varieties of the plant, 
or it may only be released under specific conditions of ionic strength, pH, or 
maceration. Studies had been done on varying conditions for extraction, including 
acidic and basic solvents, warm (50-60 ° C) or cold water, one or two extractions. Warm 
distilled water after two extractions appeared to release most of the active material. 
However, two different varieties of marijuana did not release active material under 
these same conditions. 
A study was again made on the effect of different solvents on the release of active 
material from dried plants. Samples of marijuana were extracted twice with one of 
four different solvent systems all at 55 ° C: distilled water, 10 mM EDTA, 1 mM dithio-
threitol, and 1% Triton X-100. For the first extraction material was macerated for 
four minutes in the Waring blender. The maceration was not repeated for the second 
extraction. No activity was detected in any of these samples. When a sample of one 
of these extracts was eluted from DEAE-cellulose with buffer containing 0.25M NaCl, 
and then fractionated on Fractogel TSK HW75F, no high molecular weight material 
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was detected by phenol-sulfuric acid assay for carbohydrate. This result supported 
our prior conclusion that a high molecular weight component is associated with TOP 
lowering activity. 
The effect of maceration on release of active material was then examined. Four 
samples from a variety of marijuana previously shown to have activity were each 
extracted twice with warm water (55-60 ° C). Samples were macerated in the first 
H, 
	extraction for 0, 1, 2 or 4 minutes in a Waring blender. In all cases the second 
extraction did not include maceration. Only the second extraction on the nonmacerated 
material (0 time) was active. These studies will be extended to include more gentle 
extraction and maceration conditions. 
B. Analytical Results  
The first two fractions (Samples A and B) from DEAE-cellulose chromatography 
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	of a crude, dialyzed extract eluted in 0.05M Tris-HC1, 0.10M NaC1, pH 6.7, were further 
fractionated by gel filtration on Fractogel TSK HW75F. The carbohydrate and amino acid 
composition of the resulting fractions are given in the tables below. Carbohydrate 
composition was determined by GLC of the alditol acetates essentailly using the 
method of Albersheim, et al. (Carbohyd. Res. 1967, 5, 340). Amino acid analysis was 
performed using an HPLC method modified in our laboratory. (V. T. Wiedmeier, et al, 
J. Chromatogr. 1982, 231, 410 and B. L. Karger, et al., Anal. Biochem. 1981, 115, 123). 
Samples are hydrolyzed in acid under standard conditions for protein, then dansylated, 
and the dansyl derivatives are separated and quantitated by reverse phase HPLC using 
a gradient elution system. 
In addition to carbohydrate and amino 
the percent of the total weight of the ion 
from the gel filtration column. Also the 
The ED
40 
is the amount of material require 
pressure. 
acid composition, the tables below indicate 
exchange sample represented in each fraction 
IOP activity in terms of an ED
40 
is given. 
d to bring about a 40% drop in intraocular 
Composition 
Gel Filtration 
Sample 	Fractions  
Gel Filtration 
Sample 	Fractions  
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Amino Acid A la 1 2 3 B 1 2 3 
Hydroxyproline 6 - - 9 10 3 - 6 5 
Serine 10 12 19 11 12 10 8 11 11 
Aspartic Acid 11 7 7 7 9 10 10 11 13 
Glutamic Acid 10 9 14 8 9 11 15 11 12 
Threonine -14 32 15 13 12 8 22 12 10 
Glycine 8 10 13 6 7 8 12 8 9 
Alanine 12 7 8 10 11 10 8 11 10 
Proline 5 3 3 4 7 7 5 7 9 
Valine 6 4 4 6 6 6 5 7 7 
Leucine 6 4 3 4 6 6 7 6 6 
% by Weight 
of Fraction 
5 13 18 64 5 17 78 
ED40
(pg) 0.6 2 3 0.6 >10 12 0.8 10 >10 
The high molecular weight fractions purified by gel filtration are not completely 
soluble in water. This factor has caused problems in quantifying analytical samples 
and in further purification steps. Other solvent systems were examined for their 
ability to solubilize the samples completely. A solution of 50% pyridine and water 
appears successful in solubilizing most of the material, and samples treated in this 
fashion retain IOP lowering activity. Also gel filtration was performed in the 
presence of the denaturing agent 4M guanidine-HC1 to disrupt noncovalently bound 
aggregates and promote solubility. The elution pattern was the same as that obtained 
when sodium phosphate - LiBr was the solvent system employed. Yields from this 
method are currently being compared. 
C. Chemical Modifications  
Since the large molecular weight of the active fractions poses unique 
problems, several methods were attempted to reduce the size of the material and yet 
retain activity. A sample of an active DEAE fraction was digested extensively with 
pronase, a mixture of nonspecific proteases which digest peptides to free amino acids. 
The digested sample was applied to the Fractogel gel filtration column, and the elution 
profile was compared to that of an undigested sample. Data indicated that the high 
molecular weight peaks had shifted slightly toward lower molecular weight, and a 
broader peak appeared in the region of the lowest molecular weight material. Activity 
was retained in the high molecular weight fractions. The active material was not of 
significantly lower molecular weight to make the pronase digestion useful. 
An attempt was then made to reduce the size of the carbohydrate portion of the 
molecule. Since certain 0-glycosidic linkages are susceptible to cleavage with 
alkali, an active sample obtained by gel filtration after DEAE chromatography was 
treated with 0.05M NaOH at 50 ° C in the presence of 1M NaBH4 (to prevent unwanted side 
reactions) for varying lengths of time. The 15 hour sample was polydisperse in 
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molecular weight when reapplied to the Fractogel column. However, none of the 
samples were active after this treatment including the control (0 time). Incomplete 
solubility Of some of the fractions may be a problem in these results, and the 
experiment should be repeated. 
D. Screening of Other Plants  
Not much emphasis was placed on other plants during this period. A 
pronase digest of dried Erigeron philadelphicus as well as a water extract from 
fresh plant seemed to show some activity at high doses, but no other extraction 
conditions employed so far (water extract on dried plant, 10 mM EDTA extract) 
resulted in active material. 
E. Water Soluble Cannabinoids  
No effort was made on this problem during this period. 
3. Significance to Health Problems  
In view of the fact that glaucoma is the second leading cause of blindness in 
the United States, the importance of developing new and useful drugs in this area is 
obvious. The water soluble compounds 	isolated from marijuana have a more profound 
effect (Lower IOP by 60%) than any other known compound at any dose level. Therefore, 
the potential for benefit is indeed very great. If an easy to deliver, safe, effective 
drug can be developed from this work, it would be a very significant advance in glaucoma 
therapy. In any case, due to the potency of action, both in regards to the large 
decreases in IOP and the very small dose levels, this material is of fundamental 
interest to scientists interested in glaucoma and the mechanism of pressure regulation. 
4. Research Goals During Coming Year  
1. Establish with certainty the best methodology for isolation of active 
components from Cannabis sativa. 
2. Continue established separation methods such as gel filtration, ion exchange 
and affinity chromatography, agarose electrophoresis and isoelectric focusing until a 
pure active material has been isolated. 
3. We will continue physical and chemical characterization of the above active 
fraction. 
4. Increased emphasis will be given to the area of chemical and physical 
transformations of the active material to determine which portions of the molecule 
are necessary for IOP lowering activity. 
5. Screening of other plants will be intensified. 
6. Water soluble derivatives of natural cannabinoids will be made and screened 
for activity. 
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